BR0008468A - Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectos - Google Patents
Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectosInfo
- Publication number
- BR0008468A BR0008468A BR0008468-9A BR0008468A BR0008468A BR 0008468 A BR0008468 A BR 0008468A BR 0008468 A BR0008468 A BR 0008468A BR 0008468 A BR0008468 A BR 0008468A
- Authority
- BR
- Brazil
- Prior art keywords
- hormone
- same
- agonist
- antagonist
- aspects
- Prior art date
Links
- 230000004720 fertilization Effects 0.000 title abstract 3
- 238000000338 in vitro Methods 0.000 title abstract 3
- 239000000556 agonist Substances 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 239000000960 hypophysis hormone Substances 0.000 title abstract 2
- 239000000601 hypothalamic hormone Substances 0.000 title abstract 2
- 229940043650 hypothalamic hormone Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000002552 dosage form Substances 0.000 title 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000021121 meiosis Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0609—Oocytes, oogonia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C12N2501/392—Sexual steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"MéTODO PARA FERTILIZAçãO HUMANA IN VITRO, USO DE UM HORMÈNIO HIPOTALâMICO E/OU HORMÈNIO PITUITáRIO OU DE UM AGONISTA OU ANTAGONISTA DO MESMO OU DE UM DERIVADO ATIVO DO MESMO, KIT FARMACêUTICO EM FORMA DE DOSAGEM úNICA, E, QUALQUER NOVO ASPECTO OU COMBINAçãO DE ASPECTOS". A fertilização in vitro pode ser aperfeiçoada adicionando-se um composto ativador da meiose.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199900255 | 1999-02-24 | ||
US13081699P | 1999-04-23 | 1999-04-23 | |
DKPA199901310 | 1999-09-16 | ||
PCT/DK2000/000074 WO2000050066A1 (en) | 1999-02-24 | 2000-02-23 | Treatment of infertility |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0008468A true BR0008468A (pt) | 2002-02-05 |
Family
ID=27220546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0008468-9A BR0008468A (pt) | 1999-02-24 | 2000-02-23 | Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectos |
Country Status (13)
Country | Link |
---|---|
US (1) | US6585982B1 (pt) |
EP (1) | EP1156822B1 (pt) |
JP (1) | JP2002537349A (pt) |
KR (1) | KR20010093280A (pt) |
CN (1) | CN1353617A (pt) |
AT (1) | ATE317266T1 (pt) |
AU (1) | AU2794100A (pt) |
BR (1) | BR0008468A (pt) |
CZ (1) | CZ20012967A3 (pt) |
DE (1) | DE60025905T2 (pt) |
ES (1) | ES2258445T3 (pt) |
HU (1) | HUP0200157A3 (pt) |
WO (1) | WO2000050066A1 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
EP1157096A2 (en) * | 1999-02-26 | 2001-11-28 | Novo Nordisk A/S | Culture medium comprising meiosis activating sterols (mas) and method for invitro fertilisation |
AU3376501A (en) * | 2000-02-25 | 2001-09-03 | Novo Nordisk A/S | Improvement of implantation rate |
CA2399036A1 (en) * | 2000-02-25 | 2001-08-30 | Schering Aktiengesellschaft | Improvement of implantation rate |
EP1285058A2 (en) * | 2000-05-18 | 2003-02-26 | Schering Aktiengesellschaft | Fertilization of aged oocytes |
EP1287033A2 (en) * | 2000-05-25 | 2003-03-05 | Queen's University At Kingston | Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof |
EP1216701A1 (en) * | 2000-12-22 | 2002-06-26 | Schering Aktiengesellschaft | Process to increase the concentration of meiosis-activating sterols (MAS) in the cholesterol synthesis and the use of potent inhibitors in the process |
EP1245572A1 (en) | 2001-03-26 | 2002-10-02 | Schering Aktiengesellschaft | Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation |
DK1425033T3 (da) * | 2001-09-12 | 2011-01-10 | Merck Serono Sa | Anvendelse af hCG og LH i styret ovariestimulation |
IL160780A0 (en) | 2001-09-12 | 2004-08-31 | Applied Research Systems | USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT |
AU2002324183B2 (en) * | 2001-09-12 | 2007-10-25 | Merck Serono Sa | Use of hCG and LH in controlled ovarian hyperstimulation |
WO2003070766A2 (en) * | 2002-02-22 | 2003-08-28 | Novo Nordisk A/S | A transducer of mas signalling |
JP2005518823A (ja) | 2002-03-08 | 2005-06-30 | マクギル・ユニバーシテイ | 未成熟ヒト卵母細胞の体外成熟 |
EA009371B1 (ru) * | 2002-06-07 | 2007-12-28 | Арес Трейдинг С.А. | Способ управляемой гиперстимуляции яичников и фармацевтический набор для использования в таком способе |
PL1765085T3 (pl) | 2004-05-17 | 2015-11-30 | Massachusetts Gen Hospital | Kompozycje zawierające komórki macierzyste żeńskiej linii germinalnej i sposoby ich zastosowania |
EP2422803A3 (en) | 2006-03-07 | 2013-03-13 | Geeta Shroff | Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation |
NZ706806A (en) | 2011-04-14 | 2016-12-23 | Gen Hospital Corp | Compositions and methods for autologous germline mitochondrial energy transfer |
EP3495470A1 (en) | 2011-06-29 | 2019-06-12 | The General Hospital Corporation | In vivo methods for enhancing bioenergetic status in female germ cells |
US20150272622A1 (en) | 2011-12-22 | 2015-10-01 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5563059A (en) * | 1993-02-23 | 1996-10-08 | Genentech, Inc. | Use of human inhibin and human activin to increase the number of mature primate oocytes |
US5716777A (en) * | 1994-06-23 | 1998-02-10 | Novo Nordisk A/S | Regulation of meiosis using sterols |
PL322106A1 (en) * | 1995-03-06 | 1998-01-05 | Novo Nordisk As | Meiosis stimulation |
WO1997000884A1 (en) * | 1995-06-23 | 1997-01-09 | Novo Nordisk A/S | Meiosis regulating compounds |
AU6122696A (en) * | 1995-06-23 | 1997-01-22 | Novo Nordisk A/S | Meiosis regulating compounds |
DE69721304T2 (de) * | 1996-12-20 | 2004-03-04 | Novo Nordisk A/S | Verbindungen zur Regulierung der Meiose |
CA2289524A1 (en) * | 1997-06-04 | 1998-12-10 | Akzo Nobel Nv | 17.beta.-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis |
US5866599A (en) * | 1997-06-06 | 1999-02-02 | Basf Aktiengesellschaft | Fungicidal mixtures |
CA2363074A1 (en) * | 1999-02-24 | 2000-08-31 | Novo Nordisk A/S | Treatment of infertility |
-
2000
- 2000-02-23 EP EP00906178A patent/EP1156822B1/en not_active Expired - Lifetime
- 2000-02-23 JP JP2000600676A patent/JP2002537349A/ja active Pending
- 2000-02-23 AT AT00906178T patent/ATE317266T1/de not_active IP Right Cessation
- 2000-02-23 CZ CZ20012967A patent/CZ20012967A3/cs unknown
- 2000-02-23 HU HU0200157A patent/HUP0200157A3/hu unknown
- 2000-02-23 AU AU27941/00A patent/AU2794100A/en not_active Abandoned
- 2000-02-23 ES ES00906178T patent/ES2258445T3/es not_active Expired - Lifetime
- 2000-02-23 KR KR1020017009383A patent/KR20010093280A/ko not_active Application Discontinuation
- 2000-02-23 CN CN00804135A patent/CN1353617A/zh active Pending
- 2000-02-23 BR BR0008468-9A patent/BR0008468A/pt not_active IP Right Cessation
- 2000-02-23 WO PCT/DK2000/000074 patent/WO2000050066A1/en not_active Application Discontinuation
- 2000-02-23 DE DE60025905T patent/DE60025905T2/de not_active Expired - Fee Related
- 2000-03-20 US US09/528,610 patent/US6585982B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR20010093280A (ko) | 2001-10-27 |
CN1353617A (zh) | 2002-06-12 |
JP2002537349A (ja) | 2002-11-05 |
DE60025905D1 (de) | 2006-04-20 |
WO2000050066A1 (en) | 2000-08-31 |
EP1156822A1 (en) | 2001-11-28 |
AU2794100A (en) | 2000-09-14 |
US6585982B1 (en) | 2003-07-01 |
CZ20012967A3 (cs) | 2001-12-12 |
ES2258445T3 (es) | 2006-09-01 |
ATE317266T1 (de) | 2006-02-15 |
HUP0200157A2 (hu) | 2002-05-29 |
HUP0200157A3 (en) | 2002-06-28 |
EP1156822B1 (en) | 2006-02-08 |
DE60025905T2 (de) | 2006-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0008468A (pt) | Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectos | |
PL357944A1 (en) | Intradermal-penetration agents for topical local anesthetic administration | |
ATE387430T1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
BR9510168A (pt) | Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição | |
ES2155124T3 (es) | Composiciones farmaceuticas liquidas a base de hormonas tiroideas. | |
PL347671A1 (en) | Compounds and compositions for delivering active agents | |
MXPA01008611A (es) | Compuestos y composiciones para suministrar agentes activos. | |
EP1762236A3 (en) | Formulations of alpha adrenergic receptor antagonists and their uses | |
BR0112311A (pt) | Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso | |
PT1093819E (pt) | Compostos e composicoes para fornecimento de agentes activos | |
DE60021059D1 (de) | Hydrogelpartikel formulierungen | |
BRPI0113331B8 (pt) | derivados de fenilalanina ou seus sais parmaceuticamente aceitáveis, antagonista de integrina alfa 4, agente terapêutico ou agente preventivo para doenças inflamatórias, e, composição farmacêutica | |
BR0107869A (pt) | Composições farmacêuticas eletrogiradas | |
NO980700D0 (no) | Perifert aktive anti-hyperalgesi opiater | |
BRPI0413028A (pt) | composto, uso de um composto, composição farmacêutica, e, kit farmacêutico | |
BR0110079A (pt) | Combinação de compostos orgânicos | |
BR0305628A (pt) | Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso | |
BR9709934A (pt) | Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga | |
SE0002754D0 (sv) | New pharmaceutical combination formulation and method of treatment with the combination | |
BR9709062A (pt) | Composto, composição farmacêutica, e, uso de um composto. | |
BR9912827A (pt) | Composições tópicas compreendendo um analgésico opióide e um antagonista de nmda | |
ATE311373T1 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
BR0313388A (pt) | Método para tratar, remediar ou evitar a psorìase em um paciente, uso de um composto de antagonista de cgrp, composição farmacêutica para tratamento da psorìase, e, método para identificar um composto candidato para o uso em um medicamento para tratar a psorìase | |
DE60019334D1 (de) | Antivirale arznei | |
EE200200471A (et) | Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini või selle derivaati kombinatsioonis pürimidiini derivaadiga ning on ette nähtud vähktõve raviks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A, 5A, 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007. |